Showing posts with label Pharmacy. Show all posts
Showing posts with label Pharmacy. Show all posts

Thursday, March 27, 2014

FAMU public health students secure perfect passage rate on national CHES exam

Cynthia Harris, director, FAMU Institute of Public Health
Since 2009, 19 students have become eligible to take the Certified Education Health Specialist
(CHES) credentialing exam at the FAMU Institute of Public Health. Each of those students successfully passed the exam, allowing FAMU to hold the distinction of having a 100 percent pass rate on one of the nation’s most respected health education competency exams.

The Institute of Public Health recently learned that it once again achieved this feat, securing a 100 percent pass rate on the 2013 exam and surpassing the national average score of 71.56 percent.

To succeed in passing the CHES exam, students must display extensive knowledge in the seven areas of responsibility expected of health education specialists: assessment needs, planning of programs, program implementation, evaluation of programs, program administration, acting as a resource and communications and advocacy.

Monday, October 14, 2013

FAMU College of Pharmacy to celebrate launch of Center for Health

The FAMU College of Pharmacy and Pharmaceutical Sciences will host a reception today to celebrate the launch of the Center for Health Equity.

“The Center for Health Equity has been developed to further the College of Pharmacy and Pharmaceutical Sciences’ mission by improving the health care of medically underserved populations through research, education, community intervention and service,” said Michael Thompson, PharmD, dean of the FAMU College of Pharmacy and Pharmaceutical Sciences.

This cutting-edge center represents a new inter-professional approach to identifying and solving problems related to health disparities on a local, statewide, national and global scale and involves pharmacy faculty working cooperatively with nursing, psychology, social work, medicine and public health faculty at FAMU.

Wednesday, August 21, 2013

FAMU receives $13.7M grant from Research Center in Minority Institutions

FAMU Pharmacy Professor Karam Soliman, principal investigator and a multi-million dollar grant-raiser
FAMU has been awarded $13.7 million in grants for five-years of support through the Research Center in Minority Institutions (RCMI) Program from the National Institutes of Health’s (NIH) National Institute on Minority Health and Health Disparities (NIMHD).

“The RCMI program at FAMU is designed to strengthen and expand biomedical research and research infrastructure in a major way,” said Ken Redda, professor of medicinal chemistry and interim vice president for research. “Kudos is to Dr. Karam Soliman, Dr. Carl Goodman and their terrific team in generating this significant research funding from the National Institute on Minority Health and Health Disparities. It is a bright day at FAMU.”

The RCMI grant award for the period of 2013-2018 will support drug discovery and research aimed at better understanding the makeup and risks associated with various degenerative diseases and their treatment.  The grant also will support projects in drug discovery, molecular genetics and   biotechnology research. In the area of drug discovery, the grant will aid in developing new drugs that can be used for the treatment of neurodegenerative diseases such as Parkinson’s; stroke; cancer (breast, prostate and lung); and emerging infectious diseases to uncover targets for therapy and translational research.

Tuesday, July 09, 2013

FAMU Institute of Public Health’s accreditation extended through 2020

The Council on Education for Public Health (CEPH) extended the accreditation of the FAMU Institute of Public Health through July 1, 2020. Far from a small feat, this date will mark 20 years of consecutive accreditation for the flagship program. In addition, CEPH rendered the FAMU Public Health Program as compliant on all accreditation criteria.

“I am elated to learn that our public health program has, once again, attained the maximum accreditation tenure possible from the national accrediting body,” said Cynthia Harris, FAMU Institute of Public Health director (pictured). “This achievement is the result of an outstanding team of faculty, staff, students, administrators, alumni, advisory board and a wonderful cadre of supportive community stakeholders.”

Annually, the public health program, which is housed in the College of Pharmacy and Pharmaceutical Sciences, develops and produces culturally competent public health practitioners and leaders through graduate training, research and service. The Institute of Public Health was created by the Florida Legislature in 1995. Subsequently, FAMU was given authority to initially offer the Master of Public Health (MPH) degree. Since that time, the program has grown and now offers the Doctor of Public Health (DrPH). The FAMU Public Health Program was the first accredited public health program in North Florida and the first public health program, including schools of public health, to offer the Doctor of Public Health in the state of Florida.

Friday, June 21, 2013

FAMU student wins statewide health science competition

FAMU doctoral student Terrick Andey recently won first place in the Health Sciences category during the inaugural Statewide Graduate Research Symposium. Hosted by the University of South Florida, the symposium brought together 75 graduate students from various disciplines across eight universities. Andey’s poster was titled, “Liposomal Annexin A2 Small Hairpin RNA-mediated Inhibition of Angiogenesis in Lung Cancer Stem Cells.”

“I was definitely thrilled to have had those long and lonely hours of research work recognized on such a platform,” said Andey, a Ghana native. “I perceive the award to be a validation of the progressive research environment that FAMU has has been fostering.”

Tuesday, April 16, 2013

Florida House budget includes $4M for Pharmacy Phase II

The 2013-2014 Florida House of Representatives budget appropriates $4M for Phase II of FAMU’s College of Pharmacy and Pharmaceutical Sciences building. Pharmacy Phase II is FAMU’s top construction priority.

Pharmacy Phase II will include much-needed laboratory and classroom space. FAMU Pharmacy needs this expansion in order to remain in compliance with the standards of the Accreditation Council of Pharmacy Education.

There is a total of $68M for Public Education Capital Outlay (PECO) projects in the Florida’s House’s budget. PECO dollars come from utility taxes. The state has had very little PECO money in recent years due to housing market crash and citizens shaving their energy costs by purchasing more energy efficient appliances.

Thursday, March 21, 2013

FAMU Pharmacy Phase II and Crestview campus remain top legislative priorities

Florida economists predict that the state could receive an extra $3.5 billion in tax revenue during the fiscal year ending in 2014. FAMU only needs $11,480,000 of that, barely 0.3 percent, in order to fund two budget priorities that are critical to a key research program.

The FAMU College of Pharmacy and Pharmaceutical Sciences (COPPS) remains one of the university’s top, multi-million dollar research centers. It is leading clinical and laboratory investigations to find solutions to health problems such as cancer, HIV, and “superbug” bacteria.

The university still needs $11.4M to finish up the Pharmacy Phase II building. Without that money, COPPS might be in jeopardy of failing to meet the laboratory and classroom space requirements of the Accreditation Council for Pharmacy Education.

Wednesday, March 20, 2013

FAMU pharmacy professor receives patent to kill “superbug”

Seth Y. Ablordeppey, a professor of medicinal chemistry in the College of Pharmacy and Pharmaceutical Sciences (COPPS), has received a patent to kill a “superbug” that has made headlines.

The Methicillin-Resistant Staphylococcus aureus (MRSA) is a staph infection that is commonly called a “superbug” because it is resistant to common antibiotics. Ablordeppey is developing drug compounds to combat it using plants he found in Ghana, West Africa.  His tests have revealed antibacterial activity in the plants that heals wounds.  He is looking at their extracts to see if one will kill MRSA.

If the process is successful, it could lead an inexpensive superbug treatment.

“We wanted some simple compounds that we can synthesize in a very short period of time and we are looking towards getting compounds which are not that expensive so that people can afford them,” Ablordeppey said.

Monday, August 27, 2012

FAMU trustees being urged to consider Ava Parker for presidency

The FAMU Board of Trustees hasn't officially started receiving applications in the search for the 11th university president. But that hasn’t stopped the efforts of some to make sure that the next FAMU leader is an individual who won’t show any backbone against Gov. Rick Scott or Chancellor Frank Brogan.

Rattler Nation has learned that several FAMU trustees have been asked to appoint Ava Parker as FAMU’s top administrator. Her name was circulated as a potential interim president and is still being promoted for the permanent presidency.

The argument in favor of Parker claims that she would be able to mend fences between the governor’s office and the Florida Board of Governors (BOG).

FAMU has been through this before with individuals such as ex-BOG member Castell Bryant and ex-Chancellor Debra Austin. Back when Castell was the interim president and Austin was the interim provost their administration began to cripple key research programs at the university, particularly within the College of Pharmacy and Pharmaceutical Sciences. But despite that fact, they continued to receive strong support from their friends on the BOG.

Friday, August 03, 2012

FAMU touts Crestview Ed Center as an investment in NW Florida's workforce

On Wednesday, FAMU and the City of Crestview officially opened the FAMU Rural Diversity Healthcare Center in Crestview, Fla.

“This year, FAMU celebrates its 125th anniversary as an institution of higher learning,” said Interim President Larry Robinson.  “I am convinced there is no better way to mark the occasion than by highlighting our commitment to ensure citizens of this region will have access to a high-quality education in the health professions.”

The major objective of the Crestview project is to produce high-quality graduates committed to serving the health care needs of citizens in the rural Florida Panhandle.

Wednesday, August 01, 2012

FAMU to cut ribbon on Crestview Ed Center

Today, FAMU will hold the Ribbon Cutting Ceremony for the Rural Diversity HealthCare Center located at 153 Woodruff Avenue in Crestview, Fla.

FAMU’s Crestview Education Center will be an interdisciplinary campus. According to the authorizing legislation, the center will offer "instructional programs leading to the PharmD; B.S. or M.S. nursing; master of public health and doctorate of public health; and health care management, health administration, occupational therapy, and physical therapy."

Former State Sen. Durell Peaden, R-Crestview steered a total of $11M into FAMU’s budget during the 2009 and 2010 legislative sessions in order to cover start-up costs such as facility renovations for the satellite campus. His successor, State Sen. Greg Evers, R-Baker, is working to help the FAMU center open as planned in Fall 2012 despite Gov. Rick Scott’s decision to veto the center’s $1.5M operational funding appropriation.

Thursday, July 26, 2012

FAMU Pharmacy receives $5.6M research grant to fight cancer

The National Institutes of Health (NIH) has awarded FAMU College of Pharmacy and Pharmaceutical Sciences an important and major grant from the National Institute on Minority Health and Health Disparities (NIMHD).

The grant, “Center of Excellence for Cancer Research, Training and Community Service (COE-CRTCS),” was awarded to distinguished researcher and principal investigator Karam Soliman.

“When you do research, you have to believe that your contribution will last forever and that its influence never ceases,” Soliman said.

The total amount of the award is $5,626,785 for five years. In addition, FAMU will receive $1,477,585 for five years as indirect cost.  The overall goal and objective of the grant will fund the development of innovative cancer research to address some of the most significant health consequences affecting minority and socioeconomically disadvantaged populations. Specifically, the research funded by this grant will address novel approaches for treating and preventing breast and lung cancer and promote minority health.

Saturday, June 23, 2012

FAMU pharmacy professor receives patent for drug discovery

Seth Ablordeppey, a FAMU professor in the College of Pharmacy and Pharmaceutical Sciences, has received a United States patent (No. 8,158,646) for extensive modifications to the drug Cryptolepine.  Preliminary tests indicate the drug will be effective at treating infections commonly found in HIV/AIDS, chemotherapy, and organ transplant patients. In addition, it has fewer side effects than several currently used drugs.

“This research has been in the works for more than a decade and I am grateful to FAMU for providing the environment and opportunity for this discovery,” said Ablordeppey. “With the discovery of these new agents we hope to deal one more blow to the opportunistic infections that continue to wreak havoc in our communities.”

Cryptolepine is a series of compounds derived from a native plant of Ghana, West Africa. According to the Center for Disease Control, opportunistic infections that attack weakened immune systems have become increasing problematic in the United States. When compared to drugs currently on the market, the high potency and fewer side affects associated with Cryptolepine could ultimately combat this problem.

Friday, June 01, 2012

Thompson to serve as new FAMU pharmacy dean

Michael Thompson, assistant dean for Clinical Affairs and professor of pharmacy practice at FAMU, has been appointed the new dean in the College of Pharmacy and Pharmaceutical Sciences (COPPS).

“We welcome Dr. Thompson to this new role and believe that he has the expertise to help us fulfill our goals for the College of Pharmacy,” said FAMU Provost Larry Robinson, who also serves as vice president for Academic Affairs. “Through the years, Dr. Thompson has played a major role in making pharmacy a flagship program for this campus, the state, nation and world. We have great expectations.”

Thompson has worked in COPPS since 1981 when he was hired as an assistant professor of pharmacy practice.  He was promoted to associate professor in 1987 and became a full professor in 2001.

Friday, April 20, 2012

GOP senator working to help FAMU overcome veto setback

State Sen. Greg Evers, R-Baker, is working to help FAMU’s Crestview Education Center open as planned in Fall 2012 despite Gov. Rick Scott’s decision to veto the campus’ $1.5M funding appropriation.

“Some money will be transferred to FAMU that will cover that $1.5 million for this year and funds will be put back in as a recurring expense for next year,” Baker told the Crestview Bulletin. “So it will not hold up the project; that's the bottom line.”

Baker succeeded Sen. Durell Peaden, R-Crestview, in the Florida Senate District Two seat back in 2010. Peaden steered a total of $11M into FAMU’s budget during the 2009 and 2010 legislative sessions in order to cover start-up costs such as facility renovations for the Crestview Education Center.

The transfer of $1.5M will ensure that Florida taxpayers receive a return on the millions they have already invested into satellite campus. The money is required to cover operational expenses such as salaries, utilities, and equipment.

Thursday, February 02, 2012

FAMU appoints Crestview Education Center director

Seth Y. Ablordeppey, interim dean of Florida A&M University’s (FAMU) College of Pharmacy and Pharmaceutical Sciences (COPPS) has appointed Margareth Larose-Pierre, PharmD. as the new associate dean of the FAMU-Crestview Educational Center (FCEC).

“We are delighted to have Dr. Larose-Pierre serve in this capacity, a role that she is familiar with and well qualified to step into,” said Ablordeppey. “She brings with her a wealth of knowledge and expertise that the FCEC needs, during its infancy. We are very fortunate to have her and I look forward to a bright future for the FCEC.”

Larose-Pierre received a bachelor of science in chemistry in 1984 from Florida Memorial University, her Pharm.D. degree in 1988 from FAMU’s COPPS and her ASHP-accredited residency at Jackson Memorial Hospital Department of Pharmacy. Her career expands over a period of 24 years and includes tenure at Jackson Memorial Hospital and the Veterans Affairs Medical Center in Miami as a clinical pharmacy specialist in the areas of surgery, critical care and infectious disease and as a faculty member and director of the pharmacy practice division for the FAMU College of Pharmacy in South Florida for the past 13 years.

Larose-Pierre remains a strong advocate for pharmacy students’ involvement in community activities. She and the students have been involved in screening for HTN, diabetes, HIV/AIDS, smoking cessation, breast cancer and prostate cancer. Her research interests include infectious diseases, prostate cancer, breast cancer and women’s health. She is also well published in peer-reviewed pharmacy literature.

“I am extremely excited about the opportunity to serve as the associate dean of the Crestview Educational Center,” said Larose-Pierre. “I believe in the successful expansion of the FAMU College of Pharmacy and, after visiting Crestview, I strongly believe that the partnership between FAMU and Crestview will benefit both the university and the city beyond our wildest imagination. I am thankful to everyone who worked so hard to make this venture possible and we are going to work tirelessly to make it a success of which all of us can be proud.”

Monday, January 23, 2012

Pharmacy Phase II’s future uncertain as PECO well runs dry

With state economists projecting that the Florida will not have any additional Public Education Capital Outlay (PECO) dollars for at least the next two years, the future of FAMU’s pharmacy school expansion project has become uncertain.

FAMU needs $6,049,000 to finish up Pharmacy Phase II. The university has received $25,000,000 toward the total $31,049,000 required for the project. Without that money, the College of Pharmacy and Pharmaceutical Sciences might be in jeopardy of failing to meet the laboratory and classroom space requirements of the Accreditation Council for Pharmacy Education.

Sunday, July 24, 2011

FAMU researcher receives patent to treat cancers

Nazarius Saah Lamango, an associate professor of medicinal chemistry in the FAMU College of Pharmacy and Pharmaceutical Sciences, received a patent to treat cancers using compounds that block the activity of a unique enzyme. The activity of this enzyme is elevated in some tumors. Specifically, inhibiting the excess amounts of this enzyme would diminish its ability to process the target protein into the forms that promote tumor cell growth.

Lamango further explains how this patent can benefit society.

“The patent describes compounds that can be used to inhibit the activity of an enzyme that we have found to be abnormally high in the tumors of some patients,” said Lamango. “By being able to use these compounds to bring the abnormally high enzyme activities in the tumors down to normal physiological levels, their ability to spur tumor growth will also be inhibited. When further developed into drugs, these compounds will constitute a new class of anticancer drugs with a novel mechanism of action.”

Lamango’s work was funded by grants from the National Institutes of Health (NIH). The NIH is the agency of the U.S. Federal Government tasked with managing the biomedical research budget.

Tuesday, July 19, 2011

Crestview construction to begin soon

FAMU officials have confirmed that construction is about to begin on the university's Crestview Education Center. A chain link fence now surrounds the center's future home in the downtown Alatex building.

FAMU Director of Governmental Relations Tola Thompson told the Crestview News Bulletin that the university recently hired a construction manager and submitted building plans to the City of Crestview.

The project will kick off by the end of July and take ten to 11 months to complete. FAMU expects to begin classes in the Alatex building in Fall 2012.

Former state Sen. Durell Peaden (R-Crestview) steered a total of $11M into FAMU’s budget during the 2009 and 2010 legislative sessions in order to cover the start-up costs for the Crestview Education Center. He also secured $1.5M in recurring money in 2010 for FAMU to use for salaries and operational costs at the center. The current Florida budget grants FAMU another $1.5M to continue funding the campus.

The Crestview center will be FAMU Pharmacy’s first degree-granting satellite location. The pharmacy school’s campuses in Jacksonville, Miami, and Tampa do not offer full degrees. They are used as clinical training divisions for advanced students.

Tuesday, June 21, 2011

FAMU-HCC “Bridges” program reaches 10-year anniversary

An innovative program run by the FAMU College of Pharmacy and Pharmaceutical Sciences (COPPS) reached its tenth anniversary last week.

FAMU has operated a “Bridges to Pharmaceutical Sciences” program with Hillsborough Community College (HCC) since 2001. It aims to increase the number of underrepresented minority students who enter career tracks in the pharmaceutical sciences.

FAMU helps HCC recruit a cohort of 30 students who are interested in pharmacy degrees. The two institutions then provide a variety of services that assist the students with their laboratory research skills, study habits, professionalism, and self-confidence. After the participants graduate from HCC with their associate of arts degrees they transfer into FAMU COPPS.

“Bridges” is funded by grant money FAMU receives from the National Institutes of Health (NIH). NIH has awarded a total of $982,057 to Bridges since 2001. The first principal investigator was former Pharmacy Dean Henry Lewis, III. The current principal investigator is Professor John J. Scrivens (pictured top left).